Mbio Diagnostics Inc.

Doing business as Lightdeck Diagnostics Part of Heska Corporation

UEI
HMBEH3F1D7T3
CAGE
5WYW2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Website
antechdiagnostics.com
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Mbio Diagnostics Inc.

Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, is a company that develops diagnostic tests and devices, including rapid point-of-care tests, using its proprietary Lightdeck platform technology. According to its website, Lightdeck Diagnostics offers tests for settings where lab quality results are vital in making time critical decisions, with a focus on infectious disease, water quality, food safety, and other areas.

Through past prime federal contract awards, Mbio Diagnostics Inc. has provided a variety of goods and services related to diagnostic test development, manufacturing, and distribution, primarily focused on supporting the coronavirus/COVID-19 response. This includes a $35 million contract from the Department of the Air Force to scale up manufacturing capacity for rapid COVID antigen tests, a $5.6 million contract from the Department of Health and Human Services to develop a rapid COVID antigen test and achieve regulatory clearance, and a $275,000 contract, also from HHS, to deliver a point-of-care COVID antibody test. Mbio has also provided testing devices to the National Ocean Service and developed assays for the detection of Anthrax under a subcontract with SRI International. No set aside designations were specified on these contract awards.

Through past federal grants, Mbio Diagnostics Inc. has received awards to develop and validate diagnostic tests related to water quality and food safety, including tests for per- and polyfluoroalkyl substances, harmful algal bloom toxins in shellfish, paralytic shellfish poisoning toxins, amnesic shellfish poisoning toxins, and diarrheic shellfish poisoning toxins. Major funding agencies were the National Oceanic and Atmospheric Administration and the National Institute of Food and Agriculture within the Department of Agriculture. Partners were not specified.

Quick answers

What is Mbio Diagnostics Inc.'s UEI?

Mbio Diagnostics Inc.'s Unique Entity ID (UEI) in SAM.gov is HMBEH3F1D7T3.

What is Mbio Diagnostics Inc.'s CAGE code?

Mbio Diagnostics Inc.'s CAGE code is 5WYW2.

What is Mbio Diagnostics Inc.'s primary NAICS code?

Mbio Diagnostics Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Is Mbio Diagnostics Inc. registered in SAM.gov?

Mbio Diagnostics Inc.'s SAM.gov registration expired on April 2, 2025.

Who is Mbio Diagnostics Inc.'s parent company?

Mbio Diagnostics Inc. is part of Heska Corporation.

What is Mbio Diagnostics Inc.'s most recent federal award?

Mbio Diagnostics Inc.'s most recent federal contract award is Lightdeck mini for the national ocean service hollings marine laboratory in charleston, SC (1305M222PNCNS0223), from National Oceanic and Atmospheric Administration, on August 16, 2022.

On GovTribe

See Mbio Diagnostics Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors